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Abstract
Background: The influence of serous retinal detachment (SRD) on retinal sensitivity in patients with branch retinal
vein occlusion (BRVO) and macular edema remains unclear. This is despite the frequent co-existence of SRD and
cystoid macular edema (CME) in BRVO patients on optical coherence tomography (OCT) and the fact that CME is
the most common form of macular edema secondary to BRVO. We investigated visual function (visual acuity and
macular sensitivity), macular thickness, and macular volume in patients with BRVO and macular edema.
Methods: Fifty-three consecutive BRVO patients (26 women and 27 men) were divided into two groups based on
optical coherence tomography findings. Macular function was documented by microperimetry, while macular
thickness and volume were measured by OCT.
Results: There were 15 patients with SRD and 38 patients with CME. Fourteen of the 15 patients with SRD also had
CME. Visual acuity was significantly worse in the SRD group than in the CME group (P = 0.049). Also, macular thickness
and macular volume within the central 4°, 10°, and 20° fields were significantly greater in the SRD group (P = 0.008, and
P = 0.007, P < 0.001 and P < 0.001, and P < 0.001 and P < 0.001, respectively). However, macular sensitivity within the
central 4°, 10°, and 20° fields was not significantly worse in the SRD group than in the CME group.
Conclusions: SRD itself may decrease visual acuity together with CME, because nearly all SRD patients also had
CME. SRD does not seem to influence macular function on microperimetry.
Background
Branch retinal vein occlusion (BRVO) is a common ret-
inal vascular disease that often results in macular
edema, which is the most frequent cause of visual
impairment in these patients[1,2]. Increased intravascu-
lar pressure and reduced blood flow in macular capil-
laries can lead to dysfunction of the endothelial blood-
retinal barrier and to increased vascular permeability,
resulting in macular edema[3]. Vascular endothelial
growth factor (VEGF) has been suggested to play an
important role in the pathogenesis of macular edema
[4-6]. Assessment of visual acuity and measurement of
foveal thickness by optical coherence tomography
(OCT) are widely considered to be useful for determin-
ing the treatment strategy in patients with BRVO[7].
However, BRVO causes pathological changes (such as
bleeding) that not only affect the fovea, but also the
macular region and the peripheral retina, while visual
acuity primarily reflects foveal function. Thus, more
detailed investigation into the functional implications of
anatomical and pathological changes associated with
BRVO may be important.
Recently, microperimetry has been employed to assess
visual function in BRVO patients with macular edema,
and the retinal thickness and retinal sensitivity are
reported to be related in the entire macular region
affected by BRVO[8,9]. We have previously shown that
retinal thickness and retinal volume are more closely
associated with retinal sensitivity than with BCVA in
these patients using microperimetry[10]. The influence
of serous retinal detachment (SRD) on retinal sensitivity
in BRVO patients with macular edema remains unclear,
even though SRD and cystoid macular edema (CME)
often co-exists in these patients when they are examined
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form of macular edema secondary to BRVO. Some
authors have reported a poor visual prognosis for BRVO
patients with SRD[15-18]. Accordingly, we investigated
both visual function (visual acuity and macular sensitiv-
ity) and retinal morphology (macular thickness and
macular volume) to assess the influence of SRD in
BRVO patients with macular edema.
Methods
Subjects
Informed consent to participation in this study was
obtained from each subject following an explanation of
the purpose and methods. This study was performed in
accordance with the Helsinki Declaration of 1975 (1983
revision), and it was approved by the ethics committee
of Tokyo Women’s Medical University. Fifty-six conse-
cutive patients were included in this prospective uncon-
trolled study conducted at the Department of
Ophthalmology of Tokyo Women’s Medical University
between March 2008 and November 2010 (Table 1).
Each patient had unilateral BRVO.
All of the patients had CME or SRD (≥250 μmo n
OCT) involving the foveal center. The exclusion criteria
were (1) previous ocular surgery, (2) diabetes mellitus
with diabetic retinopathy, (3) previous macular laser
photocoagulation, (4) previous intravitreal injection of
triamcinolone acetonide or anti-VEGF agents, (5) a his-
tory of ocular inflammation, and (6) marked retinal
hemorrhage (including macular bleeding involving the
intrafoveal or subfoveal spaces). Patients with marked
retinal hemorrhage were excluded from the study
because we could not judge whether SRD or CME had
an influence on retinal sensitivity, which could have
altered the results of our correlation analysis. Twenty-
eight patients had superior vein occlusion and 25
patients had inferior occlusion.
Fundus Examination
At baseline screening, patients underwent ophthalmo-
scopy and biomicroscopic examination using a slit-lamp
with a fundus contact lens. They also underwent stan-
dard fundus color photography and fluorescein angio-
graphy, which was performed with a Topcon TRC-50EX
fundus camera, an image-net system (Tokyo Optical Co.
Ltd., Japan), and a preset lens with a slit-lamp.
A masked grader independently assessed ischemic ret-
inal vascular occlusion on the fluorescein angiograms by
measuring the ischemic area of the retina with the pub-
lic domain Scion Image program, as reported previously
[4-6]. On digital photographs of the fundus, the optic
disc was outlined with a cursor and then its area was
measured, as was also done for the nonperfused area of
the retina. Then the nonperfused area was divided by
the disc area to calculate the severity of retinal ischemia.
In addition, macular sensitivity was investigated by
microperimetry, and macular thickness and macular
volume were measured by OCT.
Measurement of BCVA
Each patient underwent measurement of best-corrected
visual acuity (BCVA) with an SC-2000 System chart
(Nidek, Gamagori, Japan). BCVA was measured in deci-
mal units on a Landolt chart by orthoptists. The chart
brightness was set at 80-320 cd/m
2 and chart contrast
w a sm o r et h a n7 4 % .T h er e s u l t sw e r ec o n v e r t e dt ot h e
logarithm of the minimum angle of resolution scale (log
MAR).
Optical Coherence Tomography
OCT was performed with an instrument from Zeiss-
Humphrey Ophthalmic Systems (Zeiss Stratus OCT3,
Carl Zeiss Meditec, Dublin, CA, USA) to measure the
foveal thickness. At each visit, all patients underwent
OCT of vertical retinal cross-sections with the instru-
ment centered on the fovea and in the fast macular
thickness mode. On these views, retinal thickness was
defined as the distance between the inner surface of the
neurosensory retina and the retinal pigment epithelium.
Foveal thickness was calculated as the average macular
thickness within a circle with a radius of 500 μmc e n -
tered on the fovea. A macular thickness map and
Table 1 Baseline Clinical Features of the CME and SRD Groups
Findings CME (N = 38) SRD (N = 15) P value
Age (years) 68.2 ± 9.4
‡ 70.7 ± 10.5
‡ 0.398
Gender (female/male) 18/20 8/7 0.696
Hypertension 27 9 0.437
Systolic blood pressure (mmHg) 137 ± 15
‡ 128 ± 16
‡ 0.054
Diastolic blood pressure (mmHg) 82 ± 10
‡ 80 ± 12
‡ 0.523
Hyperlipidemia 17 6 0.754
Duration of BRVO (months) 4.4 ± 2.7
‡ 3.8 ± 1.5
‡ 0.380
Pattern of BRVO (major/macular) 24 13 0.093
Nonperfused area (disc areas) 32.6 ± 34.9
‡ 39.2 ± 37.8
‡ 0.543
BRVO = branch retinal vein occlusion; CME = cystoid macular edema; SRD = serous retinal detachment.
‡Mean ± standard deviation (SD).
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Page 2 of 7macular volume map were obtained by scanning 6 × 6
mm (20° × 20°) areas of the macular region, which was
divided into the following nine subfields: 1) fovea, 2)
superior inner macula, 3) nasal inner macula, 4) inferior
inner macula, 5) temporal inner macula, 6) superior
outer macula, 7) nasal outer macula, 8) inferior outer
macula, and 9) temporal outer macula[10]. The dia-
meters of the central, inner, and outer circles were 1, 3,
and 6 mm, respectively. Measurement of the retinal
thickness and retinal volume in each region was auto-
matically performed by computer software. The mean
macular thickness was determined for the foveal subfield
covering the central 1 × 1 mm (4° × 4°), for five sub-
fields (fovea, superior inner, nasal inner, inferior inner,
and temporal inner) covering the central 3 × 3 mm (10°
× 10°), and for all nine subfields covering the entire cen-
tral 6 × 6 mm (20° × 20°).
Macular volume was calculated as follows. A central
macular thickness map measuring 6.00 mm in diameter
was generated and this map was divided into nine quad-
rants. The diameters of the middle and inner circles were
3.00 mm and 1.00 mm, respectively. The mean macular
thickness was calculated by the Macular Volume Proto-
col of the Stratus OCT for each of the nine quadrants on
the radial scans, and then the mean thickness was mul-
tipled by the quadrant area to calculate the volume of
each quadrant. The total macular volume for the foveal
subfield covering the central 1 × 1 mm (4° × 4°), for five
subfields (fovea, superior inner, nasal inner, inferior
inner, and temporal inner) covering the central 3 × 3 mm
(10° × 10°), and for all nine subfields covering the entire
central 6 × 6 mm (20° × 20°) was thus determined as the
sum of the relevant quadrant volumes.
We divided the BRVO patients into two groups
depending on whether or not SRD was detected by
OCT[19]. SRD was defined as typical subretinal fluid
accumulation leading to detachment of the neurosen-
sory retina with low or absent reflectivity anterior to a
clearly distinguishable outer band irrespective of the
presence of CME. On the other hand, CME was defined
as hyporeflective intraretinal cavities on OCT.
Functional Mapping by Microperimetry
Microperimetry was performed with the MP-1 micro-
perimeter (Nidek, Gamagori, Japan) using an infrared
fundus camera with a liquid crystal display controlled by
dedicated software. The MP-1 performs microperimetry
and assesses fixation independently with an automated
eye tracking system that provides real-time compensa-
tion for eye movements and therefore allows presenta-
tion of a stimulus at precisely the predefined retinal
location. That is, if the reference area moves, the stimu-
lus is also automatically moved, while the stimulus is
not delivered if the reference area cannot be detected.
The macular sensitivity threshold can be measured
easily because the strength of the stimulus is altered
automatically and progressively during microperimetry.
Color fundus photographs can also be acquired and the
findings can be registered either automatically or manu-
ally along with the infrared image. At the end of testing,
microperimetry data can also be superimposed on the
digital fundus photograph. Thus, microperimetry is per-
formed while observing a target set on the fundus, so
the target is precisely located and testing is reliable even
in patients who do not have stable fixation.
Microperimetry settings were identical for all exami-
nations, and Goldmann III stimuli were presented in
random order according to a 4-2-1 double staircase
strategy. The stimulus intensity ranged from 0 to 20
decibels (dB) (0 dB corresponded to the strongest signal
intensity of 127 cd/m
2) in 1-dB steps, and the duration
of each stimulus was 200 ms. The target was varied in
size according to the patient’s visual acuity. Macular
sensitivity maps were obtained by using the macula 20
degrees program of the MP-1. Mean macular sensitivity
was calculated from the sensitivity in each of the nine
subfields on the retinal map generated by OCT[10]. The
mean macular sensitivity was determined for five loca-
tions covering the central 4° field, 29 locations covering
the central 10° field (five subfields: fovea, superior inner,
nasal inner, inferior inner, and temporal inner), and 57
locations covering the entire central 20° field (all nine
subfields).
Statistical Analysis
All analyses were performed with SAS System 9.1 soft-
ware (SAS Institute Inc., Cary, North Carolina, USA).
Results are presented as the mean ± SD or as frequen-
cies. Student’s t-test or one-way analysis of variance was
employed to compare normally distributed unpaired
continuous variables between the groups. The chi-
square test was used to compare nominal variables.
Two-tailed P values of less than 0.05 were considered to
indicate statistical significance.
Results
The BRVO patients (26 women and 27 men) were aged
68.9 ± 9.7 years (mean ± SD). The mean duration of
BRVO was 4.3 ± 2.5 months (range: 1 - 12 months).
The average nonperfused area was 34.5 ± 35.6 disc
areas, with a range of 0 to 117 disc areas. The character-
istics of the CME and SRD groups are summarized in
Table 1. Among the 53 patients with BRVO, 38 were
assigned to the CME group and 15 to the SRD group.
The mean age, female/male ratio, prevalence of hyper-
tension, prevalence of hyperlipidemia, duration of
BRVO, incidence of major BRVO, and nonperfused area
of the retina were similar in the CME and SRD groups
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Page 3 of 7(P = 0.398, P = 0.696, P = 0.437, P = 0.754, P = 0.380, P
=0 . 0 9 3 ,a n dP = 0.543, respectively). Fourteen (93%) of
the 15 patients in the SRD group had both SRD and
CME, whereas 1 patient (7%) had SRD alone.
As shown in Figure 1, visual acuity was significantly
worse in the SRD group than in the CME group (0.77 ±
0.52 vs. 0.52 ± 0.35, P = 0.049). However, as shown in
Figures 2A-C, macular sensitivity within the central 4°,
10°, and 20° fields was not significantly worse in the
SRD group than in the CME group (4.9 ± 5.2 dB, 6.3 ±
5.1 dB, and 7.1 ± 4.8 dB vs. 6.3 ± 5.4 dB, 7.7 ± 4.5 dB,
and 8.2 ± 4.1 dB, respectively; P = 0.413, P = 0.338, and
P = 0.402, respectively). Conversely, the macular thick-
ness within the central 4°, 10°, and 20° fields was signifi-
cantly greater in the SRD group than in the CME group
(578 ± 145 μm, 519 ± 109 μm, and 462 ± 83 μm vs. 462
±1 3 4μm, 417 ± 83 μm, and 375 ± 65 μm, respectively;
P = 0.008, P < 0.001, and P < 0.001, respectively) (Fig-
ures 3A-C). Also, the macular volume within the central
4°, 10°, and 20° fields was significantly greater in the
SRD group than in the CME group (0.46 ± 0.12 mm
3,
3.6 ± 0.75 mm
3,a n d1 1 . 9±1 . 9 8m m
3 vs. 0.36 ± 0.11
mm
3, 2.9 ± 0.56 mm
3, and 9.8 ± 1.59 mm
3, respectively;
P = 0.007, P < 0.001, and P < 0.001, respectively) (Fig-
ures 4A-C).
Discussion
I nt h eR E T I N As t u d y , [ 1 0 ]w ed i v i d e dt h em a c u l a r
region into nine sections, which were (1) fovea, 2)
superior inner macula, 3) nasal inner macula, 4) infer-
ior inner macula, 5) temporal inner macula, 6) superior
outer macula, 7) nasal outer macula, 8) inferior outer
macula, and 9) temporal outer macula). We found that
retinal sensitivity and thickness were correlated in each
section, and multiple regression analysis confirmed
this. In the present study, we divided the macular
region into the following three sections: 1) 1 × 1 mm
(4° × 4°) (corresponding to the fovea section in the
R E T I N As t u d y ) ,2 )3×3m m( 1 0 °×1 0 ° )
Figure 1 Best-corrected visual acuity (BCVA) of the CME and
SRD groups converted to the logarithm of the minimum angle
of resolution scale (log MAR). There was a significant difference of
visual acuity between the two groups (P = 0.049).
Figure 2 Macular sensitivity in the CME and SRD groups. There
were no significant differences of macular sensitivity within the
central (A) 4°, (B) 10°, and (C) 20° fields between the two groups (P
= 0.413, P = 0.338, and P = 0.402, respectively).
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inner, inferior inner, and temporal inner sections), and
3) 6 × 6 mm (20° × 20°) (corresponding to all 9 sec-
tions). Then we investigated whether the retinal sensi-
tivity and thickness of these 3 sections showed any
differences between patients with SRD and those with
CME.
We found that the mean visual acuity (log MAR) was
significantly worse in the SRD group than the CME
group, a result that is in agreement with previous
reports,[15-18] although a lower percentage of our
patients had SRD compared with the other reports
[12,14,15]. The inner half of the fovea contains an
inverted cone-shaped zone of Müller cells (the Müller
Figure 3 Macular thickness in the CME and SRD groups.T h e r e
were significant differences of macular thickness within the central
(A) 4°, (B) 10°, and (C) 20° fields between the two groups (P = 0.008,
P < 0.001, and P < 0.001, respectively).
Figure 4 Macular volume in the CME and SRD groups.T h e r e
were significant differences of macular volume within the central
(A) 4°, (B) 10°, and (C) 20° fields between the two groups (P = 0.007,
P < 0.001, and P < 0.001, respectively).
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Page 5 of 7cell cone), the apex of which is located at the external
limiting membrane (ELM) of the fovea centralis. The
cytoplasm of cells in this cone extends obliquely out-
ward and forms the internal limiting membrane at the
clivus of the foveal depression[20,21]. In eyes with ret-
inal vein occlusion, leakage from the affected retinal
capillaries accumulates around the fovea and causes ret-
inal thickening, which may cause the internal limiting
membrane at the clivus of the fovea to protrude with
formation of foveal cystoid spaces[15]. The cytoplasm of
the Müller cell cone would then extend perpendicularly
in the walls of the foveal cystoid spaces. When leakage
increases, further traction on the Müller cell cone would
lead to traction on the inner and outer segments of the
foveal photoreceptors, resulting in a small area of retinal
detachment at the fovea[15]. Subsequently, SRD would
occur when the ELM barrier breaks down at the fovea
[15]. Loss of the ELM barrier often results in damage to
foveal photoreceptors in the outer segment and impair-
ment of visual acuity. Thus, the mean visual acuity of
the SRD group may have been significantly worse
because of damage to foveal photoreceptor cells due to
foveal detachment. In addition, nearly all of the SRD
patients in this study also had CME. Therefore, SRD
itself may decrease visual acuity together with CME.
Interestingly, unlike the results for visual acuity, macu-
lar sensitivity within the central 4°, 10°, and 20° fields
was not significantly worse in the SRD group than in
the CME group. This suggests that SRD itself has no
influence on macular sensitivity because there was no
difference of sensitivity between the SRD and CME
groups. Therefore, evaluation of both visual acuity and
macular sensitivity may be important in BRVO patients
to detect the effects of macular edema. There is evi-
dence that the visual function of BRVO patients after
treatment of macular edema is not fully described by
measuring visual acuity: 1) Subjects with good visual
acuity sometimes have difficulty seeing certain objects
and the opposite also occurs[9]. 2) In some BRVO
patients, there is no improvement of visual acuity after
improvement of macular edema and SRD[22-24]. Thus,
evaluation of both visual acuity and macular sensitivity
may be clinically important for assessing visual function
in BRVO patients with SRD. However, microperimetry
may be less informative when the edema is very severe
and visual acuity is poor, in which case macular sensitiv-
ity was reduced significantly in both groups.
We also found that the macular thickness within the
central 4°, 10°, and 20° fields was significantly greater in
the SRD group than in the CME group. Macular thick-
ness increases along with vascular permeability, and the
macular region and peripheral retina have abundant
capillaries unlike the fovea, so extra-foveal BRVO could
influence both retinal thickness and volume at the fovea.
In BRVO patients, SRD may be caused by transudation
of extracellular fluid into the subretinal space,[11-15]
with the site of detachment being determined by the
foveal architecture, especially the presence of the Müller
cell cone[15]. In addition, when the barrier function of
the ELM breaks down due to traction on the Müller cell
cone, intraretinal fluid will move into the subretinal
space, resulting in an increase of SRD and alleviation of
retinal edema[15]. This may explain why macular thick-
ness and volume were significantly greater in the SRD
group than the CME group.
Surprisingly, macular sensitivity and the macular
thickness/volume within the central 4°, 10°, and 20°
fields did not show parallel changes in the present
study, although we have previously reported that retinal
thickness and retinal volume show a closer association
with retinal sensitivity than with BCVA in BRVO
patients with macular edema[10]. This may be because
the influence of SRD on retinal function is weak since
SRD is mainly caused by transudation of extracellular
fluid into the subretinal space[11-15]. In addition,
because there is little traction on the Müller cell cone in
the macular region, except at the fovea,[15] the follow-
ing processes 1)-4) leading to SRD may not occur in the
macular region apart from at the fovea. 1) Traction on
the Müller cell cone leads to traction on the inner and
outer segments of the photoreceptors. 2) Traction on
the photoreceptors causes breakdown of the barrier
function of the ELM. 3) Loss of ELM barrier function
results in damage to the outer segment photoreceptors.
4) Damage to the outer segment photoreceptors reduces
macular sensitivity. Because it is unclear why macular
sensitivity and macular thickness/volume did not show
parallel changes in our BRVO patients with SRD, further
investigation is needed to clarify the relations between
macular function and morphology.
One limitation of this study is that it was cross-sec-
tional and thus did not provide data on the response to
treatment or prognosis of our patients, such as whether
subjects with or without SRD had any particular out-
comes. Because it has been reported that diffuse disor-
ganization of the outer photoreceptor layer beneath the
fovea often leads to poor visual acuity after complete
resolution of macular edema and SRD,[22-24] it is possi-
ble that such diffuse disorganization of the outer photo-
receptors could have affected visual acuity in our
patients. In addition, Tsujikawa and associates[15]
reported that dome-shaped retinal detachment is some-
times associated with a focal defect of the outer segment
photoreceptors above the site of SRD, so the visual
prognosis would be poor if such a defect involved the
fovea. However, we could not assess the influence of
changes at the junction between the inner and outer
segments of the photoreceptor layer on the visual
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Page 6 of 7prognosis because detection of this junction was difficult
with our OCT equipment. Moreover, small pointed ret-
inal detachment (the initial stage of SRD [15]) may have
been present in the CME group, but we could not assess
such detachment with our OCT equipment. Accord-
ingly, the prognosis of patients with BRVO and SRD
needs to be investigated in more detail in the future.
Conclusions
The mean visual acuity of the SRD group was worse
than that of the CME group, but the macular sensitivity
of the two groups did not differ significantly. This sug-
g e s t st h a tS R Di t s e l fm a yb er e l a t e dt oad e c r e a s eo f
visual acuity together with CME, because nearly all of
the SRD patients also had CME. However, SRD had no
influence on macular sensitivity because there was no
difference of sensitivity between the SRD and CME
groups.
Author details
1Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women’s
Medical University, Chiba, Japan.
2Department of Ophthalmology, University
of Tokyo Graduate School of Medicine, Tokyo, Japan.
3Department of
Hygiene and Public Health II, Tokyo Women’s Medical University, Tokyo,
Japan.
Authors’ contributions
HN, and HF were involved in the design and conduct of the study.
Collection and management of the data were done by HN, and KS, while
analysis and interpretation of the data were performed by HN, HF, TM, and
KS. Preparation of the first draft of the manuscript was done by HN, and
review and approval of the manuscript was performed by HF and TM. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 April 2011 Accepted: 26 September 2011
Published: 26 September 2011
References
1. Michels RG, Gass JD: The natural course of retinal branch vein
obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:166-177.
2. Gutman FA, Zegarra H: The natural course of temporal retinal branch
vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:178-192.
3. Noma H, Funatsu H, Sakata K, Harino S, Nagaoka T, Mimura T, Sone T,
Hori S: Macular microcirculation and macular oedema in branch retinal
vein occlusion. Br J Ophthalmol 2009, 93:630-633.
4. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K,
Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK:
Pathogenesis of macular edema with branch retinal vein occlusion and
intraocular levels of vascular endothelial growth factor and interleukin-6.
Am J Ophthalmol 2005, 140:256-261.
5. Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H,
Mishima HK: Intravitreal levels of vascular endothelial growth factor and
interleukin-6 are correlated with macular edema in branch retinal vein
occlusion. Graefes Arch Clin Exp Ophthalmol 2006, 244:309-315.
6. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T,
Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK: Aqueous
humour levels of cytokines are correlated to vitreous levels and severity
of macular oedema in branch retinal vein occlusion. Eye 2008, 22:42-48.
7. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME,
Cohen G: Baseline predictors of visual acuity and retinal thickness
outcomes in patients with retinal vein occlusion: Standard Care Versus
COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology
2011, 118:345-352.
8. Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N: Perimetric
sensitivity with the micro perimeter 1 and retinal thickness in patients
with branch retinal vein occlusion. Am J Ophthalmol 2007, 143:342-344.
9. Yamaike N, Tsujikawa A, Sakamoto A, Ota M, Kotera Y, Miyamoto K, Kita M,
Yoshimura N: Retinal sensitivity after intravitreal injection of
bevacizumab for the treatment of macular edema secondary to retinal
vein occlusion. Retina 2009, 29:757-767.
10. Noma H, Funatsu H, Mimura T, Harino S, Shimada K: Functional-
Morphological Correlates in Patients With Branch Retinal Vein Occlusion
and Macular Edema. Retina in press .
11. Lerche RC, Schaudig U, Scholz F, Walter A, Richard G: Structural changes of
the retina in retinal vein occlusion–imaging and quantification with
optical coherence tomography. Ophthalmic Surg Lasers 2001, 32:272-280.
12. Spaide RF, Lee JK, Klancnik JK Jr, Gross NE: Optical coherence tomography
of branch retinal vein occlusion. Retina 2003, 23:343-347.
13. Yamaguchi Y, Otani T, Kishi S: Serous macular detachment in branch
retinal vein occlusion. Retina 2006, 26:1029-1033.
14. Shroff D, Mehta DK, Arora R, Narula R, Chauhan D: Natural history of
macular status in recent-onset branch retinal vein occlusion: an optical
coherence tomography study. Int Ophthalmol 2008, 28:261-268.
15. Tsujikawa A, Sakamoto A, Ota M, Kotera Y, Oh H, Miyamoto K, Kita M,
Yoshimura N: Serous retinal detachment associated with retinal vein
occlusion. Am J Ophthalmol 2010, 149:291-301.
16. Ohashi H, Oh H, Nishiwaki H, Nonaka A, Takagi H: Delayed absorption of
macular edema accompanying serous retinal detachment after grid
laser treatment in patients with branch retinal vein occlusion.
Ophthalmology 2004, 111:2050-2056.
17. Karacorlu M, Ozdemir H, Karacorlu SA: Resolution of serous macular
detachment after intravitreal triamcinolone acetonide treatment of
patients with branch retinal vein occlusion. Retina 2005, 25:856-860.
18. Parodi MB, G DIS, Ravalico G: Grid laser treatment for exudative retinal
detachment secondary to ischemic branch retinal vein occlusion. Retina
2008, 28:97-102.
19. Park SP, Ahn JK, Mun GH: Aqueous vascular endothelial growth factor
levels are associated with serous macular detachment secondary to
branch retinal vein occlusion. Retina 2010, 30:281-286.
20. Yamada E: Some structural features of the fovea centralis in the human
retina. Arch Ophthalmol 1969, 82:151-159.
21. Gass JD: Muller cell cone, an overlooked part of the anatomy of the
fovea centralis: hypotheses concerning its role in the pathogenesis of
macular hole and foveomacualr retinoschisis. Arch Ophthalmol 1999,
117:821-823.
22. Murakami T, Tsujikawa A, Ohta M, Miyamoto K, Kita M, Watanabe D,
Takagi H, Yoshimura N: Photoreceptor status after resolved macular
edema in branch retinal vein occlusion treated with tissue plasminogen
activator. Am J Ophthalmol 2007, 143:171-173.
23. Ota M, Tsujikawa A, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Kotera Y,
Yoshimura N: Integrity of foveal photoreceptor layer in central retinal
vein occlusion. Retina 2008, 28:1502-1508.
24. Ota M, Tsujikawa A, Murakami T, Yamaike N, Sakamoto A, Kotera Y,
Miyamoto K, Kita M, Yoshimura N: Foveal photoreceptor layer in eyes
with persistent cystoid macular edema associated with branch retinal
vein occlusion. Am J Ophthalmol 2008, 145:273-280.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2415/11/29/prepub
doi:10.1186/1471-2415-11-29
Cite this article as: Noma et al.: Visual function and serous retinal
detachment in patients with branch retinal vein occlusion and macular
edema: a case series. BMC Ophthalmology 2011 11:29.
Noma et al. BMC Ophthalmology 2011, 11:29
http://www.biomedcentral.com/1471-2415/11/29
Page 7 of 7